Cerence Inc.
For the period ended Sep 30, 2025. Filed Nov 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Nov 20, 2025
CRNC$8.61-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of September 30, 202 and
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts)
| September 30, 2025 | September 30, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $84,017 | $121,485 |
| Marketable securities | 3,433 | 5,502 |
| Accounts receivable, net of allowances of $68 and $1,614 at September 30, 2025 and September 30, 2024, respectively | 58,937 | 62,755 |
| Deferred costs | 4,481 | 5,286 |
| Prepaid expenses and other current assets | 39,889 | 70,481 |
| Total current assets | 190,757 | 265,509 |
| Long-term marketable securities | — | 3,453 |
| Property and equipment, net | 35,761 | 30,139 |
| Deferred costs | 15,501 | 18,051 |
| Operating lease right of use assets | 16,762 | 12,879 |
| Goodwill | 299,003 | 296,858 |
| Intangible assets, net | — | 1,706 |
| Deferred tax assets | 54,207 | 51,398 |
| Other assets | 18,600 | 22,365 |
| Total assets | $630,591 | $702,358 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $901 | $3,959 |
| Deferred revenue | 51,865 | 52,822 |
| Short-term operating lease liabilities | 4,344 | 4,528 |
| Short-term debt | — | 87,094 |
| Accrued expenses and other current liabilities | 44,080 | 68,405 |
| Total current liabilities | 101,190 | 216,808 |
| Long-term debt, net of discounts and issuance costs | 199,693 | 194,812 |
| Deferred revenue, net of current portion | 140,021 | 114,354 |
| Long-term operating lease liabilities | 13,083 | 8,803 |
| Other liabilities | 25,928 | 26,484 |
| Total liabilities | 479,915 | 561,261 |
| Commitments and contingencies (Note 13) | ||
| Stockholders' Equity: | ||
| Common stock, $0.01 par value, 560,000 shares authorized as of September 30, 2025; 43,374 and 41,924 shares issued and outstanding as of September 30, 2025 and September 30, 2024, respectively | 434 | 419 |
| Accumulated other comprehensive loss | (25,469) | (25,912) |
| Additional paid-in capital | 1,116,165 | 1,088,330 |
| Accumulated deficit | (940,454) | (921,740) |
| Total stockholders' equity | 150,676 | 141,097 |
| Total liabilities and stockholders' equity | $630,591 | $702,358 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.